The role of junctional adhesion molecules in vascular inflammation

Nature Reviews Immunology

Volumn 7, Issue 6, 2007, Pages 467-477

  Weber, Christian ^a   Fraemohs, Line ^a   Dejana, Elisabetta ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BETA2 INTEGRIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GUANOSINE TRIPHOSPHATASE; JUNCTIONAL ADHESION MOLECULE 4; JUNCTIONAL ADHESION MOLECULE A; JUNCTIONAL ADHESION MOLECULE B; JUNCTIONAL ADHESION MOLECULE C; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PROTEIN AMICA1; RAP1 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANGIOGENESIS; BACTERIAL MENINGITIS; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; DENDRITIC CELL; DISEASE MODEL; EXPERIMENTAL MOUSE; GENETIC MANIPULATION; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LIVER ISCHEMIA; MENINGITIS; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NONHUMAN; PATHOPHYSIOLOGY; PERITONITIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; SKIN INFLAMMATION; TUMOR GROWTH; VASCULITIS;

ANIMALS; BLOOD VESSELS; CAPILLARY PERMEABILITY; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; LEUKOCYTE ROLLING; MODELS, IMMUNOLOGICAL;

EID: 34249650761     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2096     Document Type: Review

References (81)

1. Muller, W. A. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 24, 327-334 (2003).
2. Imhof, B. A. & Aurrand-Lions, M. Adhesion mechanisms regulating the migration of monocytes. Nature Rev. Immunol. 4, 432-444 (2004).
3. Weber, C. Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules. J. Mol. Med. 81, 4-19 (2003).
4. Bazzoni, G. The JAM family of junctional adhesion molecules. Curr. Opin. Cell Biol. 15, 525-530 (2003).
5. Martin-Padura, I. et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142, 117-127 (1998). This paper reports the identification of JAM-A at intercellular junctions and its involvement in mononuclear transmigration.
6. Williams, L. A., Martin-Padura, I., Dejana, E., Hogg, N. & Simmons, D. L. Identification and characterisation of human junctional adhesion molecule (JAM). Mol. Immunol. 36, 1175-1188 (1999).
7. Palmeri, D., van Zante, A., Huang, C. C., Hemmerich, S. & Rosen, S. D. Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J. Biol. Chem. 275, 19139-19145 (2000).
8. Cunningham, S. A. et al. A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions. J. Biol. Chem. 275, 34750-34756 (2000).
9. Aurrand-Lions, M., Duncan, L., Ballestrem, C. & Imhof, B. A. JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J. Biol. Chem. 276, 2733-2741 (2001).
10. Arrate, M. P., Rodriguez, J. M., Tran, T. M., Brock, T. A. & Cunningham, S. A. Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J. Biol. Chem. 276, 45826-45832 (2001).
11. Liang, T. W. et al. Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM3. J. Immunol. 168, 1618-1626 (2002).
12. Hirabayashi, S. et al. JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1. Mol. Cell. Biol. 23, 4267-4282 (2003).
13. Moog-Lutz, C. et al. JAML, a novel protein with characteristics of a junctional adhesion molecule, is induced during differentiation of myeloid leukemia cells. Blood 102, 3371-3378 (2003).
14. Kostrewa, D. et al. X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J. 20, 4391-4398 (2001).
15. Prota, A. E. et al. Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding. Proc. Natl Acad. Sci. USA 100, 5366-5371 (2003).
16. Liu, Y. et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. J. Cell Sci. 113 2363-2374 (2000).
17. Johnson-Leger, C. A., Aurrand-Lions, M., Beltraminelli, N., Fasel, N. & Imhof, B. A. Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration. Blood 100, 2479-2486 (2002).
18. Santoso, S. et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J. Exp. Med. 196, 679-691 (2002). In this paper the leukocyte integrin MAC1 is reported to act as a receptor for JAM-C, which supports a crucial role for JAMs in platelet-mediated leukocyte recruitment.
19. Aurrand-Lions, M. et al. Junctional adhesion molecule-C regulates the early influx of leukocytes into tissues during inflammation. J. Immunol. 174, 6406-6415 (2005).
20. Bazzoni, G. et al. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J. Biol. Chem. 275, 20520-20526 (2000).
21. Ebnet, K., Schulz, C. U., Meyer Zu Brickwedde, M. K., Pendl, G. G. & Vestweber, D. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J. Biol. Chem. 275, 27979-27988 (2000).
22. Ebnet, K. et al. The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). EMBO J. 20, 3738-3748 (2001).
23. Zen, K. et al. JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration. Mol. Biol. Cell 15, 3926-3937 (2004).
24. Ebnet, K. et al. The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity. J. Cell Sci. 116, 3879-3891 (2003).
25. Mandicourt, G., Iden, S., Ebnet, K., Aurrand-Lions, M. & Imhof, B. A. JAM-C regulates tight junctions and integrin-mediated cell adhesion and migration. J. Biol. Chem. 282, 1830-1837 (2006).
26. Ozaki, H. et al. Cutting edge: combined treatment of TNF-α and IFN-γ causes redistribution of junctional adhesion molecule in human endothelial cells. J. Immunol. 163, 553-557 (1999).
27. 2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nature Immunol. 3, 151-158 (2002). This paper identifies JAM-A as a new ligand for the leukocyte integrin LFA1 and provides the first evidence for a functional relevance of heterophilic JAM interactions.
28. Shaw, S. K. et al. Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-α plus interferon-γ does not reduce leukocyte transmigration under flow. Am. J. Pathol. 159, 2281-2291 (2001).
29. 3-integrin complex and its role in angiogenesis.
30. Keiper, T. et al. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J. 19, 2078-2080 (2005).
31. Ostermann, G. et al. Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. Arterioscler. Thromb. Vasc. Biol. 25, 729-735 (2005).
32. Slevin, M. et al. Identification of differential protein expression associated with development of unstable human carotid plaques. Am. J. Pathol. 168, 1004-1021 (2006).
33. Babinska, A. et al. The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques. Thromb. Haemost. 97, 272-281 (2007).
34. Khandoga, A. et al. Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration. Blood 106, 725-733 (2005). This paper implicates endothelial-cell JAM-A in the extravasation of neutrophils in vivo using genetically deficient mice in a model of ischaemia-reperfusion injury of the liver.
35. Aurrand-Lions, M., Johnson-Leger, C., Wong, C., Du Pasquier, L. & Imhof, B. A. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood 98, 3699-3707 (2001).
36. Naik, U. P., Naik, M. U., Eckfeld, K., Martin-DeLeon, P. & Spychala, J. Characterization and chromosomal localization of JAM-1, a platelet receptor for a stimulatory monoclonal antibody. J. Cell Sci. 114, 539-547 (2001).
37. Bazzoni, G. et al. Homophilic interaction of junctional adhesion molecule. J. Biol. Chem. 275, 30970-30976 (2000).
38. Babinska, A. et al. F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis. Thromb. Haemost. 88, 843-850 (2002).
39. Santoso, S. et al. The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions. J. Biol. Chem. 280, 36326-36333 (2005).
40. 2 integrin: function in junctional complexes and leukocyte adhesion. Mol. Biol. Cell 16, 4992-5003 (2005). This paper provides an interesting analysis of the heterophilic interactions of endothelial-cell JAM-B and JAM-C and its modulation of JAM-C interactions with MAC1.
41. Bazzoni, G. Endothelial tight junctions: permeable barriers of the vessel wall. Thromb. Haemost. 95, 36-42 (2006).
42. 1 integrins and Rap1 activity. J. Biol. Chem. 280, 11665-11674 (2005).
43. Mandell, K. J., McCall, I. C. & Parkos, C. A. Involvement of the junctional adhesion molecule-1 (JAM1) homodimer interface in regulation of epithelial barrier function. J. Biol. Chem. 279, 16254-16262 (2004).
44. Orlova, V. V., Economopoulou, M., Lupu, F., Santoso, S. & Chavakis, T. Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J. Exp. Med. 203, 2703-2714 (2006).
45. Del Maschio, A. et al. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J. Exp. Med. 190, 1351-1356 (1999).
46. Lechner, F. et al. Antibodies to the junctional adhesion molecule cause disruption of endothelial cells and do not prevent leukocyte influx into the meninges after viral or bacterial infection. J. Infect. Dis. 182, 978-982 (2000).
47. Zernecke, A. et al. Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler. Thromb. Vasc. Biol. 26, e10-e13 (2006). This paper reports the first evidence for an important role for JAM-A in neointimal lesion formation and monocyte infiltration after arterial denudation injury.
48. Chavakis, T. et al. The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo. J. Biol. Chem. 279, 55602-55608 (2004).
49. 2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the I domain. J. Immunol. 173, 6259-6264 (2004).
50. 3 specific. J. Cell. Sci. 119, 490-499 (2006).
51. Boettner, B., Govek, E. E., Cross, J. & Van Aelst, L. The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin. Proc. Natl Acad. Sci. USA 97, 9064-9069 (2000).
52. 1. Facilitation by JAM3. J. Biol. Chem. 277, 27589-27592 (2002).
53. Shaw, S. K. et al. Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration. J. Exp. Med. 200, 1571-1580 (2004).
54. 2 integrin avidity in transendothelial chemotaxis of mononuclear cells. J. Immunol.159, 3968-3975 (1997).
55. Springer, T. A. & Wang, J. H. The three-dimensional structure of integrins and their ligands, and conformational regulation of cell adhesion. Adv. Protein Chem. 68, 29-63 (2004).
56. Smith, A. et al. A talin-dependent LFA-1 focal zone is formed by rapidly migrating T lymphocytes. J. Cell Biol. 170, 141-151 (2005).
57. Wojcikiewicz, E. P., Azad, H., Koenen, R. R., Moy, V. T. & Weber, C. Homophilic and heterophilic interactions of JAM-A measured using atomic force microscopy. Miami Winter Symp. Short Rep. 18, 31 (2007).
58. Corada, M. et al. Junctional adhesion molecule-A-deficient polymorphonuclear cells show reduced diapedesis in peritonitis and heart ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA 102, 10634-10639 (2005). This paper describes an interesting role of leukocyte JAM-A in neutrophil polarization and directed migration during inflammatory extravasation.
59. Chavakis, T., Preissner, K. T. & Santoso, S. Leukocyte trans-endothelial migration: JAMs add new pieces to the puzzle. Thromb. Haemost. 89, 13-17 (2003).
60. von Hundelshausen, P. & Weber, C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ. Res. 100, 27-40 (2007).
61. Kornecki, E., Walkowiak, B., Naik, U. P. & Ehrlich, Y. H. Activation of human platelets by a stimulatory monoclonal antibody. J. Biol. Chem. 265, 10042-10048 (1990).
62. Mause, S. F., von Hundelshausen, P., Zernecke, A., Koenen, R. R. & Weber, C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler. Thromb. Vasc. Biol. 25, 1512-1518 (2005).
63. 3 and stimulated by platelet-activating factor. J. Clin. Invest. 100, 2085-2093 (1997).
64. Cera, M. R. et al. Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. J. Clin. Invest. 114, 729-738 (2004).
65. Cooke, V. G., Naik, M. U. & Naik, U. P. Fibroblast growth factor-2 failed to induce angiogenesis in junctional adhesion molecule-deficient mice. Arterioscler. Thromb. Vasc. Biol. 26, 2005-2011 (2006).
66. Naik, M. U., Vuppalanchi, D. & Naik, U. P. Essential role of junctional adhesion molecule-1 in basic fibroblast growth factor-induced endothelial cell migration. Arterioscler. Thromb. Vasc. Biol. 23, 2165-2171 (2003).
67. Lamagna, C., Hodivala-Dilke, K. M., Imhof, B. A. & Aurrand-Lions, M. Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth. Cancer Res. 65, 5703-5710 (2005).
68. Fuse, C., Ishida, Y., Hikita, T., Asai, T. & Oku, N. Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma. J. Biol. Chem. 282, 8276-8283 (2007).
69. Martinez-Mier, G., Toledo-Pereyra, L. H. & Ward, P. A. Adhesion molecules in liver ischemia and reperfusion. J. Surg. Res. 94, 185-194 (2000).
70. Weber, C., Schober, A. & Zernecke, A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler. Thromb. Vasc. Biol. 24, 1997-2008 (2004).
71. Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695 (2005).
72. Pajukanta, P. et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nature Genet. 36, 371-376 (2004).
73. Huertas-Vazquez, A. et al. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1. Arterioscler. Thromb. Vasc. Biol. 25, 1985-1991 (2005).
74. Huo, Y. et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nature Med. 9, 61-67 (2003).
75. von Hundelshausen, P. et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103, 1772-1777 (2001).
76. Nasdala, I. et al. A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. J. Biol. Chem. 277, 16294-16303 (2002).
77. Wegmann, F. et al. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J. Exp. Med. 203, 1671-1677 (2006).
78. Cohen, C. J. et al. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc. Natl Acad. Sci. USA 98, 15191-15196 (2001).
79. Vincent, T., Pettersson, R. F., Crystal, R. G. & Leopold, P. L. Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells. J. Virol. 78, 8047-8058 (2004).
80. Coyne, C. B., Voelker, T., Pichla, S. L. & Bergelson, J. M. The coxsackievirus and adenovirus receptor interacts with the multi-PDZ domain protein-1 (MUPP1) within the tight junction. J. Biol. Chem. 279, 48079-48084 (2004).
81. Mirza, M. et al. Coxsackievirus and adenovirus receptor (CAR) is expressed in male germ cells and forms a complex with the differentiation factor JAM-C in mouse testis. Exp. Cell Res. 312, 817-830 (2006).